FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/04/085317 [Registered on: 22/04/2025] Trial Registered Prospectively
Last Modified On: 18/04/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Bruhatyadi Dhoopan and Neembadi Dhoopan Herbal Smoke Treatments to Reduce Pain After Surgery for Common Ano Rectal Problems 
Scientific Title of Study   Randomized Controlled Clinical Trial Of Bruhatyadi Dhoopan And Neembadi Dhoopan For The Management Of Post Operative Pain In Benign Anorectal Diseases 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Jigar Darji  
Designation  PG Scholar 
Affiliation  Parul University 
Address  Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda

Vadodara
GUJARAT
391760
India 
Phone  6355536316  
Fax    
Email  jigardarji024@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Parikshit Shirode 
Designation  Professor 
Affiliation  Parul University 
Address  Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda, Vadodra Gujrat

Vadodara
GUJARAT
391760
India 
Phone  9960063588  
Fax    
Email  parikshit.shirode260038@paruluniversity.ac.in  
 
Details of Contact Person
Public Query
 
Name  Dr Parikshit Shirode 
Designation  Professor 
Affiliation  Parul University 
Address  Parul Institute Of Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda, Vadodra Gujrat

Vadodara
GUJARAT
391760
India 
Phone  9960063588  
Fax    
Email  parikshit.shirode260038@paruluniversity.ac.in  
 
Source of Monetary or Material Support  
Parul Institute OF Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat India 391760 
 
Primary Sponsor  
Name  Parul Institute Of Ayurved 
Address  Parul Institute OF Ayurved Department Of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat India 391760 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jigar Darji  Parul Institute Of Ayurved  Parul Institute of Ayurved Department of Shalya Tantra 4th Floor Room No 403 Parul University Limda Vadodra Gujrat
Vadodara
GUJARAT 
6355536316

jigardarji024@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics committee Parul Institute Of Ayurved   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K629||Disease of anus and rectum, unspecified. Ayurveda Condition: SULAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Bruhati , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(2) Medicine Name: Ashwagandha , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(3) Medicine Name: Pippali , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(4) Medicine Name: Tulsi , Reference: Charak Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
2Comparator ArmDrugClassical(1) Medicine Name: Nimba, Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(2) Medicine Name: Gour Sarsha, Reference: Shusrut Samhita , Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(3) Medicine Name: Guggulu , Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
(4) Medicine Name: Vacha , Reference: Shusrut Samhita, Route: Topical, Dosage Form: Churna/ Powder, Dose: 7(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: No, Additional Information: -Used As Dhoopan
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients undergone anorectal surgeries and suffering from pain of intensity 7 to 10 on vas scale will be enrolled for Dhoopan procedure.
2.Patients wilfully giving well informed written consent.
3.Age group between- 20 years to 60 years.
 
 
ExclusionCriteria 
Details  1.Patients with disorders like Malignancy, Syphilis, Tuberculosis, Leprosy
2. HIV+ve, HBsAg+ve, VDRL+ve,
3.Patient with uncontrolled diabetes mellitus and hypertension.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Post Operative Pain Reductions Without Use of Oral Pain Killers
 
from commencement of pain reduction in
between 1 hours, 6 hours ,12 hours ,24
hours postoperatively for 5 days post
operative days
 
 
Secondary Outcome  
Outcome  TimePoints 
No Gastric Acid Reflux Will Be Seen Due To intake No Need Of Painkiller In Post Operative Period   from commencement of pain reduction in
between 1 hours, 6 hours ,12 hours ,24
hours postoperatively for 5 days post
operative days
 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   09/05/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Ano-rectal conditions like hemorrhoids, fistula in ano, chronic fissure associated with sentinel tag are common conditions requiring surgical excision followed by significant post operative pain, making effective pain management crucial for patient recovery.
Conventional pain medications may have side effects such as gastrointestinal issues and dependency, necessitating safer, alternative treatments. Incorporating traditional medicine with modern post-surgical care could provide a more comprehensive approach to pain management.Ayurvedic formulations like Bruhatyadi Dhoopan and Neembadi Dhoopan may offer natural and holistic pain relief options without adverse effects, but clinical evidence is lacking.This study aims to evaluate the clinical efficacy of Bruhatyadi Dhoopan and Neembadi Dhoopan for managment of post operative ano-rectal pain.The study will assess pain reduction (VAS scale),  patient satisfaction, and adverse effects over seven days post-surgery. 
Hence the need and uniqueness of study.
 
Close